92 related articles for article (PubMed ID: 17442497)
1. Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency.
Lippi G; Franchini M; Salvagno GL; Guidi GC
Cancer Treat Rev; 2007 Aug; 33(5):427-36. PubMed ID: 17442497
[TBL] [Abstract][Full Text] [Related]
2. Angiostatin.
Cao Y; Xue L
Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800
[TBL] [Abstract][Full Text] [Related]
3. Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth.
Shen L; Zhu X; Wang Y; Zeng W; Wu G; Xue H; Chen B
Biol Chem; 2008 Feb; 389(2):135-41. PubMed ID: 18163888
[TBL] [Abstract][Full Text] [Related]
4. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
5. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated.
Wahl ML; Kenan DJ; Gonzalez-Gronow M; Pizzo SV
J Cell Biochem; 2005 Oct; 96(2):242-61. PubMed ID: 16094651
[TBL] [Abstract][Full Text] [Related]
7. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer.
Xu Z; Shi H; Li Q; Mei Q; Bao J; Shen Y; Xu J
Oncol Rep; 2008 Jul; 20(1):81-8. PubMed ID: 18575722
[TBL] [Abstract][Full Text] [Related]
8. Kringle structures and antiangiogenesis.
Cao Y; Cao R; Veitonmäki N
Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):667-81. PubMed ID: 12678719
[TBL] [Abstract][Full Text] [Related]
9. [Hyperlipoprotein (a)-emia determined by genetic polymorphisms in apolipoprotein (a) gene].
Ichinose A
Brain Nerve; 2008 Nov; 60(11):1307-17. PubMed ID: 19069164
[TBL] [Abstract][Full Text] [Related]
10. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
11. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
12. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer.
Schmitz V; Raskopf E; Gonzalez-Carmona MA; Vogt A; Kornek M; Sauerbruch T; Caselmann WH
Cancer Invest; 2008 Jun; 26(5):464-70. PubMed ID: 18568768
[TBL] [Abstract][Full Text] [Related]
14. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
Crawford Y; Ferrara N
Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein(a), an enigmatic anti-angiogenic glycoprotein in human plasma: A curse or cure?
Kalaivani V; Jaleel A
Pharmacol Res; 2020 Aug; 158():104858. PubMed ID: 32430285
[TBL] [Abstract][Full Text] [Related]
17. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic therapy against gastrointestinal tract cancers.
Iwasaki J; Nihira S
Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies.
Kohandel M; Kardar M; Milosevic M; Sivaloganathan S
Phys Med Biol; 2007 Jul; 52(13):3665-77. PubMed ID: 17664569
[TBL] [Abstract][Full Text] [Related]
20. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]